Arcutis Biotherapeutics, Inc. ARQT Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s interest expense?
- Arcutis Biotherapeutics, Inc. (ARQT) reported interest expense of $4.37M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s interest expense changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s interest expense increased by 46.5% year-over-year, from $2.98M to $4.37M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.